Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
HER2-directed Biosimilar in Breast Cancer: Real World ePRO
ClinicalTrials.gov study NCT05234021. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
ClinicalTrials.gov study NCT05710328. IPD Sharing: Not stated. Countries: 2. Publications: 1.
TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery
ClinicalTrials.gov study NCT03881878. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2
ClinicalTrials.gov study NCT03556345. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis
ClinicalTrials.gov study NCT01377363. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
ClinicalTrials.gov study NCT02675829. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05203445. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer.
ClinicalTrials.gov study NCT05425550. IPD Sharing: NO. Countries: 1. Publications: 22.
Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03147963. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
ClinicalTrials.gov study NCT00629616. IPD Sharing: Not stated. Countries: 1. Publications: 3.
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
ClinicalTrials.gov study NCT04246671. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT03588091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
ClinicalTrials.gov study NCT06830382. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status
ClinicalTrials.gov study NCT04807595. IPD Sharing: YES. Countries: 10. Publications: 1.
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
ClinicalTrials.gov study NCT01428414. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
ClinicalTrials.gov study NCT00511459. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
ClinicalTrials.gov study NCT00968968. IPD Sharing: YES. Countries: 2. Publications: 0.
Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System
ClinicalTrials.gov study NCT05165602. IPD Sharing: NO. Countries: 1. Publications: 14.
Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC
ClinicalTrials.gov study NCT05400993. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer
ClinicalTrials.gov study NCT04293276. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.